Heritage Global Partners to Conduct Court-Approved Auction of CaaStle, Inc.'s Clothing Inventory and Industrial Laundry Equipment
Auction Details:
This large-scale sale features commercial laundry systems, warehouse infrastructure, and a significant quantity of premium branded clothing inventory, providing an opportunity for secondary market retailers, commercial laundry operators, 3PL/logistics providers, and apparel resellers to acquire high-value equipment and merchandise.
Featured Assets Include:
Apparel inventory from Ralph Lauren, Ba&sh, Maje, Ann Taylor, Banana Republic, and more
(8) Realstar KM803 Dry Cleaning Systems
(7) Wascomat EX677CL Commercial Washing Machines
Wascomat EX645CL Commercial Washing Machines
(6) Wascomet D783 Commercial Washing Machines
(12) Wascomat TD83 Commercial Dryers
(4) Leonard IM96SH Steam Tunnel Systems
(300+) Garment Racks
Pallet Racking
(50+) Zebra Label Printers (ZD420, ZT410 models)
JLG ES3246 Electric Scissor Lift
Raymond R40 Reach Truck
(150+) Uline Vinyl Basket Trucks
(150+) Uline Poly Box Trucks
And much more
'This auction includes a comprehensive offering of late-model commercial laundry systems and thousands of high-quality apparel units from top-tier brands,' said David Barkoff, Senior Vice President at Heritage Global Partners. 'We believe this rare opportunity represents an ideal sale for buyers across fashion resale, logistics, and textile services looking for well-maintained, ready-to-deploy assets.'
Heritage Global Partners, Inc. ('HGP')
HGP is a subsidiary of Heritage Global Inc. (NASDAQ: HGBL). HGP operates under the Industrial Assets business unit and is a full-service auction, liquidation and asset advisory firm which holds a prominent spot in the industrial sectors including Aerospace, Automotive, Aviation, Biotech, Broadcast & Postproduction, Chemical, Electronics Manufacturing, Energy, Food & Beverage, Heavy Construction, Metalworking, Oil & Gas, Pharmaceutical, Plastics, Printing, Real estate, Semiconductor, Solar, Textile & Woodworking, and others. HGP conducts 150-200 auction projects per year, globally.
Heritage Global Inc. ('HG')
HG values and monetizes industrial & financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. This aids in facilitating the circular economy by diverting useful industrial assets from landfills and operating an ethical supply chain by overseeing post-sale account activity of financial assets. Specialties consist of acting as an adviser, in addition to acquiring or brokering turnkey manufacturing facilities, surplus industrial machinery and equipment, industrial inventories, real estate, and charged-off account receivable portfolios through its two business units: Industrial Assets and Financial Assets.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
27 minutes ago
- Business Wire
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially misleading business information to the investing public. So What: If you purchased Telix securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. What to do next: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. What is this about: On July 22, 2025, Telix disclosed receipt of a subpoena from the U.S. Securities and Exchange Commission, which was 'seeking various documents and information primarily relating to the Company's disclosures regarding the development of the Company's prostate cancer therapeutic candidates.' On this news, Telix's American Depositary Receipt ('ADR') price fell $1.70 per ADR, or 10.44%, to close at $14.58 per ADR on July 23, 2025. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Attorney Advertising. Prior results do not guarantee a similar outcome.
Yahoo
an hour ago
- Yahoo
Why Canadian Solar Plummeted Today
Key Points Canadian Solar's second-quarter results came in below expectations, with a tepid outlook. President Trump also said his administration would not approve any more solar projects, calling wind and solar "the scam of the century." The entire solar sector was down on the news, but Canadian Solar especially so. 10 stocks we like better than Canadian Solar › Shares of solar module manufacturer and project developer Canadian Solar (NASDAQ: CSIQ) plunged 18% on Thursday as of 2:05 p.m. ET. Canadian Solar faced a double whammy today. Not only did President Donald Trump make comments on social media that eviscerated the entire solar sector, but Canadian Solar also delivered an underwhelming Q2 earnings report. A miss on both lines and uncertainty about the future In the second quarter, Canadian Solar's revenue grew just 3.9%, with an adjusted (non-GAAP) net loss per share of $0.53. While both figures improved relative to the prior-year quarter, they handily missed analyst estimates. The company did point out its solar module shipments came in at the higher end of the guidance range, and gross margin exceeded the high end. However, that gross margin was helped out by the one-time recognition of an unrealized gain for sales-type leasing, and module volumes were driven by a surge of orders in China. In other words, these figures were higher than normal, with the gross margin improvement based largely on accounting. CEO Shawn Qu also forecast a slowdown, saying, "Following the surge in installations in China during the first half, we expect demand to normalize as the market adjusts to a new paradigm." To that end, management forecast just $1.4 billion in revenue at the midpoint for the third quarter, down from $1.73 billion in the second quarter, with gross margin normalizing down to 15% at the midpoint. Speaking of Qu's mention of a "new paradigm," President Donald Trump cast a pall over the entire solar sector today with a post on his social media platform, Truth Social, writing: Any State that has built and relied on WINDMILLS and SOLAR for power are seeing RECORD BREAKING INCREASES IN ELECTRICITY AND ENERGY COSTS. THE SCAM OF THE CENTURY! We will not approve wind or farmer destroying Solar. The days of stupidity are over in the USA!!! MAGA It wasn't clear exactly what prompted Trump's threat to not approve any more solar projects. Electricity prices have increased over the past year, but experts attribute that to the rise of energy-hungry artificial intelligence (AI) data centers and onshore manufacturing, initiatives that Trump has supported, and which have lifted prices in states with both lots of renewables and little renewables alike. Solar stocks under the microscope Solar stocks have continued to largely struggle this year, seemingly validating the fears ever since last year's election. Clearly, the administration is hostile to solar and wind projects, so the industry will have to figure out how to navigate this overhang. On the bright-ish side, only 23% of Canadian Solar's development pipeline comes from North America. So while more restrictions on U.S. solar projects would be a headwind, the company may be able to continue diversifying away from the U.S. for its growth. Should you buy stock in Canadian Solar right now? Before you buy stock in Canadian Solar, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Canadian Solar wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $654,624!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,075,117!* Now, it's worth noting Stock Advisor's total average return is 1,049% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Billy Duberstein and/or his clients no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Canadian Solar Plummeted Today was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
NDSN Q2 Deep Dive: Advanced Technology and Medical Segments Drive Growth, Strategic Portfolio Shifts Continue
Manufacturing company Nordson (NASDAQ:NDSN) reported Q2 CY2025 results exceeding the market's revenue expectations , with sales up 12.1% year on year to $741.5 million. Its non-GAAP profit of $2.73 per share was 3.5% above analysts' consensus estimates. Is now the time to buy NDSN? Find out in our full research report (it's free). Nordson (NDSN) Q2 CY2025 Highlights: Revenue: $741.5 million vs analyst estimates of $722.2 million (12.1% year-on-year growth, 2.7% beat) Adjusted EPS: $2.73 vs analyst estimates of $2.64 (3.5% beat) Adjusted EBITDA: $238.5 million vs analyst estimates of $230.1 million (32.2% margin, 3.7% beat) Operating Margin: 25.3%, in line with the same quarter last year Organic Revenue rose 2.1% year on year vs analyst estimates of flat growth (144.6 basis point beat) Market Capitalization: $12.07 billion StockStory's Take Nordson's second quarter was marked by strong demand in its Advanced Technology Solutions and Medical and Fluid Solutions segments, which helped the company surpass Wall Street expectations for both revenue and non-GAAP earnings per share. Management credited the ongoing integration of the Atrion acquisition as a key factor in expanding the medical product portfolio, particularly in proprietary fluid delivery and cardiovascular solutions. CEO Sundaram Nagarajan pointed to operational execution and sustained commercial momentum in core end markets as drivers of profit improvement and free cash flow, stating, 'This operational performance reflects solid execution of the integration plan as well as the ongoing deployment of NBS Next.' Looking forward, Nordson's outlook is shaped by anticipated continued strength in Advanced Technology Solutions, normalization in medical device demand, and stabilization in select industrial markets. Management believes secular drivers—such as increased demand for semiconductor packaging, the aging population, and a shift to noninvasive medical procedures—will support growth, but acknowledged that uncertainty remains in the broader trade environment. Nagarajan indicated, 'Our growth framework ensures new products are a growing source of organic growth and competitive advantage,' while cautioning that ongoing trade policy shifts and customer order timing could influence results in the coming quarters. Key Insights from Management's Remarks Management attributed the quarter's outperformance to robust growth in advanced electronics, successful integration of recent acquisitions, and focused execution in dynamic end markets. Advanced Technology Solutions momentum: The segment delivered double-digit organic sales growth, driven by demand for electronics dispense products and measurement systems, especially in Asia-Pacific. Management highlighted that repositioning the product portfolio and regional manufacturing, along with short lead times, enabled Nordson to capture new opportunities as supply chains shifted. Atrion acquisition impact: The Atrion medical portfolio added significantly to revenue and profitability, with accretive earnings contributions arriving a year ahead of initial expectations. Management emphasized that the integration accelerated operational efficiencies and expanded Nordson's proprietary offering in medical infusion and cardiovascular markets. Medical segment normalization: After several quarters of inventory destocking, the medical fluid component business returned to high single-digit growth, and interventional solutions stabilized. Management believes the core medical business is on track for normal organic growth, supported by underlying trends like population aging and demand for less invasive procedures. Industrial Precision Solutions stabilization: While demand remained weak for polymer processing and automotive-related coatings, resilience in packaging, nonwoven, and precision agriculture applications helped mitigate the impact. Management noted that certain segments appear to have hit their trough, with expectations for sequential improvement as market conditions stabilize. Operational excellence and cash flow: The quarter featured record free cash flow, driven by sustained improvements in working capital management. This allowed for continued debt reduction, share repurchases, and ongoing investment in new product development, reflecting Nordson's balanced capital deployment strategy. Drivers of Future Performance Nordson expects future performance to depend on new product adoption in semiconductors and medical, as well as recovering demand in core industrial markets. Growth in semiconductor packaging: Management expects continued momentum in electronics-related applications, particularly as Nordson's solutions support advanced semiconductor packaging for artificial intelligence and cloud computing. The company is investing in R&D and sees opportunities as customers redesign supply chains to mitigate tariff risks. Medical device pipeline and market trends: With the normalization of inventory levels, the medical segment is positioned for high single-digit organic growth. Secular trends such as population aging and a shift toward noninvasive procedures are expected to drive demand, supported by recent product launches and a healthy pipeline. Macroeconomic and trade uncertainties: While management is optimistic about sequential improvement in industrial precision markets, it cautioned that ongoing volatility in global trade policy and customer capital spending cycles could affect order timing and growth rates. Targeted restructuring is expected to yield annual cost benefits, but near-term variability remains a risk. Catalysts in Upcoming Quarters In the coming quarters, our analysts will monitor (1) new product adoption rates in semiconductor and medical device applications, (2) the pace of recovery in industrial precision and polymer processing end markets, and (3) the impact of ongoing restructuring and portfolio optimization, including the divestiture of contract manufacturing. The trajectory of global trade policy and customer capital spending will also be key variables to watch. Nordson currently trades at $221.35, up from $213.51 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it's free). Stocks That Trumped Tariffs Trump's April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines. Take advantage of the rebound by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
